BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15066754)

  • 1. On the formulation of pH-sensitive liposomes with long circulation times.
    Simões S; Moreira JN; Fonseca C; Düzgüneş N; de Lima MC
    Adv Drug Deliv Rev; 2004 Apr; 56(7):947-65. PubMed ID: 15066754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo.
    Slepushkin VA; Simões S; Dazin P; Newman MS; Guo LS; Pedroso de Lima MC; Düzgüneş N
    J Biol Chem; 1997 Jan; 272(4):2382-8. PubMed ID: 8999949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.
    Duan Y; Wei L; Petryk J; Ruddy TD
    Int J Nanomedicine; 2016; 11():5697-5708. PubMed ID: 27843312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units.
    Momekova D; Rangelov S; Yanev S; Nikolova E; Konstantinov S; Romberg B; Storm G; Lambov N
    Eur J Pharm Sci; 2007 Dec; 32(4-5):308-17. PubMed ID: 17928206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the pH-sensitive mechanism of tumor-targeting liposomes.
    Fan Y; Chen C; Huang Y; Zhang F; Lin G
    Colloids Surf B Biointerfaces; 2017 Mar; 151():19-25. PubMed ID: 27940165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
    Fattal E; Couvreur P; Dubernet C
    Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system.
    Hong MS; Lim SJ; Oh YK; Kim CK
    J Pharm Pharmacol; 2002 Jan; 54(1):51-8. PubMed ID: 11829129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes.
    Simões S; Slepushkin V; Düzgünes N; Pedroso de Lima MC
    Biochim Biophys Acta; 2001 Nov; 1515(1):23-37. PubMed ID: 11597349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-circulating, pH-sensitive liposomes.
    Momekova D; Rangelov S; Lambov N
    Methods Mol Biol; 2010; 605():527-44. PubMed ID: 20072904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
    Garg A; Kokkoli E
    Curr Pharm Biotechnol; 2011 Aug; 12(8):1135-43. PubMed ID: 21470144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusogenic activity of PEGylated pH-sensitive liposomes.
    Vanić Z; Barnert S; Süss R; Schubert R
    J Liposome Res; 2012 Jun; 22(2):148-57. PubMed ID: 22149717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of pH-sensitive liposomes constructed by poly(2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery.
    Xu H; Hu M; Yu X; Li Y; Fu Y; Zhou X; Zhang D; Li J
    Eur J Pharm Biopharm; 2015 Apr; 91():66-74. PubMed ID: 25660909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery.
    Paliwal SR; Paliwal R; Vyas SP
    Drug Deliv; 2015 May; 22(3):231-42. PubMed ID: 24524308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate.
    Guo X; Szoka FC
    Bioconjug Chem; 2001; 12(2):291-300. PubMed ID: 11312691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between pH-sensitive liposomes and model membranes.
    Bergstrand N; Arfvidsson MC; Kim JM; Thompson DH; Edwards K
    Biophys Chem; 2003 May; 104(1):361-79. PubMed ID: 12834854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
    Dos Santos N; Mayer LD; Abraham SA; Gallagher RC; Cox KA; Tardi PG; Bally MB
    Biochim Biophys Acta; 2002 Apr; 1561(2):188-201. PubMed ID: 11997119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pH-sensitive liposome formulation containing oleyl alcohol.
    Sudimack JJ; Guo W; Tjarks W; Lee RJ
    Biochim Biophys Acta; 2002 Aug; 1564(1):31-7. PubMed ID: 12100993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic Insight into How PEGylation Reduces the Efficacy of pH-Sensitive Liposomes from Molecular Dynamics Simulations.
    Mahmoudzadeh M; Magarkar A; Koivuniemi A; Róg T; Bunker A
    Mol Pharm; 2021 Jul; 18(7):2612-2621. PubMed ID: 34096310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
    Fenske DB; Cullis PR
    Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target.
    Klibanov AL; Maruyama K; Beckerleg AM; Torchilin VP; Huang L
    Biochim Biophys Acta; 1991 Feb; 1062(2):142-8. PubMed ID: 2004104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.